FDA Approves Gene Therapy for Rare Muscular Dystrophy FDA Approves Gene Therapy for Rare Muscular Dystrophy
The health regulator has granted accelerated approval to Sarepta Therapeutics ' first-of-its-kind gene therapy for Duchenne muscular dystrophy.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
More News: Brain | Gene Therapy | Genetics | Health | Muscular Dystrophy | Neurology | Neurosurgery | Reflex Sympathetic Dystrophy